US Patent 10124131 | Patents | Expiry | Expiration | Dates

TEVA BRANDED PHARM

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Israel Flag Israel

Post An Enquiry

Virtual Booth

ALBUTEROL SULFATE

Supporting Information : Click here to upload a PDF

US Patent Number

10124131

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2031-05-18

Patent Use Code

Delist Requested

Application Number

205636

Patent Use Description

Product Number

2

TEVA BRANDED PHARM

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Israel Flag Israel

Post An Enquiry

Virtual Booth

ALBUTEROL SULFATE

Supporting Information : Click here to upload a PDF

US Patent Number

10124131

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2031-05-18

Patent Use Code

Delist Requested

Application Number

205636

Patent Use Description

Product Number

1

TEVA PHARM

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Israel Flag Israel

Post An Enquiry

Virtual Booth

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Supporting Information : Click here to upload a PDF

US Patent Number

10124131

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2031-05-18

Patent Use Code

Delist Requested

Application Number

208799

Patent Use Description

Product Number

2

TEVA PHARM

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Israel Flag Israel

Post An Enquiry

Virtual Booth

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Supporting Information : Click here to upload a PDF

US Patent Number

10124131

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2031-05-18

Patent Use Code

Delist Requested

Application Number

208799

Patent Use Description

Product Number

3

TEVA PHARM

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Israel Flag Israel

Post An Enquiry

Virtual Booth

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Supporting Information : Click here to upload a PDF

US Patent Number

10124131

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2031-05-18

Patent Use Code

Delist Requested

Application Number

208799

Patent Use Description

Product Number

1

TEVA PHARM

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Israel Flag Israel

Post An Enquiry

Virtual Booth

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Supporting Information : Click here to upload a PDF

US Patent Number

10124131

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2031-05-18

Patent Use Code

Delist Requested

Application Number

208799

Patent Use Description

Product Number

6

TEVA PHARM

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Israel Flag Israel

Post An Enquiry

Virtual Booth

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Supporting Information : Click here to upload a PDF

US Patent Number

10124131

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2031-05-18

Patent Use Code

Delist Requested

Application Number

208799

Patent Use Description

Product Number

4

TEVA PHARM

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Israel Flag Israel

Post An Enquiry

Virtual Booth

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Supporting Information : Click here to upload a PDF

US Patent Number

10124131

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2031-05-18

Patent Use Code

Delist Requested

Application Number

208799

Patent Use Description

Product Number

5

TEVA PHARM

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Israel Flag Israel

Post An Enquiry

Virtual Booth

FLUTICASONE PROPIONATE

Supporting Information : Click here to upload a PDF

US Patent Number

10124131

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2031-05-18

Patent Use Code

Delist Requested

Application Number

208798

Patent Use Description

Product Number

3

TEVA PHARM

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Israel Flag Israel

Post An Enquiry

Virtual Booth

FLUTICASONE PROPIONATE

Supporting Information : Click here to upload a PDF

US Patent Number

10124131

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2031-05-18

Patent Use Code

Delist Requested

Application Number

208798

Patent Use Description

Product Number

1

TEVA PHARM

Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

Israel Flag Israel

Post An Enquiry

Virtual Booth

FLUTICASONE PROPIONATE

Supporting Information : Click here to upload a PDF

US Patent Number

10124131

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2031-05-18

Patent Use Code

Delist Requested

Application Number

208798

Patent Use Description

Product Number

Find

Information, Expiry & Status of FDA Orange Book Patents covering 10124131

Y

2031-05-18

2

Y

2031-05-18

1

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Y

2031-05-18

2

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Y

2031-05-18

3

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Y

2031-05-18

1

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Y

2031-05-18

6

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Y

2031-05-18

4

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE

Y

2031-05-18

5

Y

2031-05-18

3

Y

2031-05-18

1

Y

2031-05-18

2